CerCell
Private Company
Funding information not available
Overview
CerCell A/S is a Copenhagen-based developer and manufacturer of customized single-use bioprocessing equipment, operating as a subsidiary of the Swiss Stobbe Group. The company leverages a modular design philosophy to offer configurable single-use bioreactors, fermenters, and mixers, primarily targeting the cell therapy, viral vector, and mRNA production markets. With a focus on flexibility and compatibility with any process control system, CerCell serves pharmaceutical and biotech clients requiring non-standard, small-to-medium scale production solutions. Its technology is rooted in expertise from a European research project on advanced ceramic materials and adherent cell cultivation.
Technology Platform
Modular, configurable single-use bioprocessing equipment platform using rigid plastics. Offers tailored assemblies from a library of over 5,000 parts for bioreactors (SUB), fermenters (SUF), and mixers (SUM), compatible with any process control system.
Opportunities
Risk Factors
Competitive Landscape
CerCell competes in the single-use bioprocessing market dominated by large corporations like Cytiva (Danaher), Thermo Fisher Scientific, and Sartorius. Its primary competitive advantage is extreme configurability and focus on rigid plastic systems, differentiating it from the bag-based standard offerings of the giants. It likely also competes with smaller specialty firms and in-house engineering solutions at biotech companies.